ArticleComputational and structural biotechnology journal2022

Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma.

Ning Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.